New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Alphatec Holdings, Inc.
ATEC
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

808M

Medical - Devices

Next Earning date - 30 Oct 2024

808M

Medical - Devices

Next Earning date - 30 Oct 2024

5.75USD
Shape0.45 ( 8.49%)
favorite-chart

Relative Strenght

14
favorite-chart

Volume Buzz

27%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

67%

Quote Panel

Shape
Updated October 17, 2024
1W 11.65 % 1M -6.50 % 3M -48.01 % 1Y -51.31 %

Key Metrics

Shape
  • Market Cap

    807.65M


  • Shares Outstanding

    140.46M


  • Share in Float

    98.59M


  • Dividende

    0


  • Earning Date

    30 Oct 2024


  • Price Target

    5.75


  • Average Volume

    2.43M


  • Beta

    1.39


  • Range

    4.88-17.34


  • Industry

    Medical - Devices


  • Website

    https://www.atecspine.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.49x

P/S Ratio

20.15x

P/B Ratio

12.9

Debt/Equity

-33.5%

Net Margin

$-1.3

EPS

How ATEC compares to sector?

P/E Ratio

Relative Strength

Shape

ATEC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$727M

Shape400%

2025-Revenue

$0.62

Shape-114%

2025-EPS

$219M

Shape-1721%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Morgan Stanley

downgrade

Previous: Overweight

2024-08-01

Now: Equal-Weight

Barclays

initialise

Previous: Not converted

2024-07-08

Now: Overweight

Morgan Stanley

initialise

Previous: Not converted

2022-09-12

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.35
vs -0.43

Q4.22

arrow
arrow

N/A

-0.33
vs -0.40

Q1.23

arrow
arrow

N/A

-0.40
vs -0.43

Q2.23

arrow
arrow

N/A

-0.43
vs -0.36

Q3.23

arrow
arrow

N/A

-0.35
vs -0.35

Q4.23

arrow
arrow

N/A

-0.37
vs -0.33

Q1.24

arrow
arrow

N/A

-0.34
vs -0.40

Q2.24

arrow
arrow

N/A

-0.29
vs -0.43

Q3.24

arrow
arrow

N/A

-0.11
vs -0.35

Q4.24

arrow
arrow

N/A

-0.04
vs -0.37

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+43%

89.8M  vs 62.9M

Q4.22

arrow
arrow

+43%

105.9M  vs 74M

Q1.23

arrow
arrow

+54%

109.1M  vs 70.9M

Q2.23

arrow
arrow

+39%

116.9M  vs 84.2M

Q3.23

arrow
arrow

+32%

118.3M  vs 89.8M

Q4.23

arrow
arrow

+30%

138M  vs 105.9M

Q1.24

arrow
arrow

+27%

138.5M  vs 109.1M

Q2.24

arrow
arrow

+25%

145.6M  vs 116.9M

Q3.24

arrow
arrow

+24%

147.2M  vs 118.3M

Q4.24

arrow
arrow

+24%

170.8M  vs 138M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+164%

1.64
vs -3.54

Q4.22

arrow
arrow

+95%

0.95
vs 1.64

Q1.23

arrow
arrow

+75%

0.75
vs 0.95

Q2.23

arrow
arrow

+182%

1.82
vs 0.75

Q3.23

arrow
arrow

+97%

0.97
vs 1.82

Q4.23

arrow
arrow

-48%

-0.48
vs 0.97

Q1.24

arrow
arrow

-79%

-0.79
vs -0.48

Q2.24

arrow
arrow

-100%

-1.00
vs -0.79

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

164

164
vs 161

2%

Q4.22

arrow
arrow

185

185
vs 164

13%

Q1.23

arrow
arrow

187

187
vs 185

1%

Q2.23

arrow
arrow

214

214
vs 187

14%

Q3.23

arrow
arrow

203

203
vs 214

-5%

Q4.23

arrow
arrow

208

208
vs 203

2%

Q1.24

arrow
arrow

234

234
vs 208

13%

Q2.24

arrow
arrow

221

221
vs 234

-6%

Earnings Growth

Latest News